当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析

凯赛生物

(688065)

  

流通市值:316.25亿  总市值:391.01亿
流通股本:5.83亿   总股本:7.21亿

凯赛生物(688065)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润4.23亿元,每股收益0.67元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2121693.62万元,未分配利润246965.27万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2344510.79万元,负债222817.17万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,545,040,722.51,670,767,942.21775,769,935.752,957,911,554.76
营业总成本1,946,642,190.871,283,596,878.98619,368,581.392,361,273,032.48
其他经营收益
营业利润506,943,908.68345,764,406.94161,685,700.77551,561,171.61
利润总额503,419,479.27342,112,439.58158,040,889.01548,015,229.03
净利润422,904,719.22284,191,771.38124,318,691.92474,589,331.67
每股收益
其他综合收益4,490,569.414,035,669.853,862,477.8-5,486,780.85
综合收益总额427,395,288.63288,227,441.23128,181,169.72469,102,550.82
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计11,491,267,292.3612,011,651,589.2812,947,798,435.287,386,914,396.78
非流动资产:
非流动资产合计11,953,840,606.3511,809,531,078.4711,742,069,967.911,634,562,952.86
资产总计23,445,107,898.7123,821,182,667.7524,689,868,403.1819,021,477,349.64
流动负债:
流动负债合计1,655,968,953.741,876,141,935.872,538,495,884.892,917,855,546.03
非流动负债:
非流动负债合计572,202,742.26870,251,506.821,006,056,817.11,002,549,593.88
负债合计2,228,171,6962,746,393,442.693,544,552,701.993,920,405,139.91
所有者权益(或股东权益):
归属于母公司股东权益合计17,597,943,048.9117,452,567,422.3817,563,815,224.8111,507,005,495.25
股东权益合计21,216,936,202.7121,074,789,225.0621,145,315,701.1915,101,072,209.73
负债和股东权益合计23,445,107,898.7123,821,182,667.7524,689,868,403.1819,021,477,349.64
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,602,327,524.21,812,430,577.73744,764,366.483,351,448,965.93
经营活动现金流出小计2,329,234,301.961,473,116,722.4657,274,979.572,530,519,633.51
经营活动产生的现金流量净额273,093,222.24339,313,855.3287,489,386.91820,929,332.42
投资活动产生的现金流量:
投资活动现金流入小计2,343,262,658.28410,102,862.31-20,252,268.74
投资活动现金流出小计3,786,164,041.341,883,735,109.6305,227,020.78843,313,170.45
投资活动产生的现金流量净额-1,442,901,383.06-1,473,632,247.29-305,227,020.78-823,060,901.71
筹资活动产生的现金流量:
筹资活动现金流入小计6,482,952,613.246,458,513,203.026,293,622,576.951,889,290,806.48
筹资活动现金流出小计2,410,831,730.531,822,280,245.26628,364,962.171,739,798,822.61
筹资活动产生的现金流量净额4,072,120,882.714,636,232,957.765,665,257,614.78149,491,983.87
汇率变动对现金及现金等价物的影响-25,487,758.21-4,105,233.672,366,523.9924,824,735.62
现金及现金等价物净增加额2,876,824,963.683,497,809,332.125,449,886,504.9172,185,150.2
期末现金及现金等价物余额8,062,789,676.88,683,774,045.2410,635,851,218.025,185,964,713.12
补充资料:
现金及现金等价物的净增加额-3,497,809,332.12-172,185,150.2
最新报告期:2025-11-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券王彤,肖亚平0.901.131.422025-11-25
华安证券刘天其,王强峰0.951.181.562025-11-10
TOP↑